nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Boiling Point
|
Bisbas, Georgia |
|
|
9 |
2 |
p. 109 |
artikel |
2 |
Correction to Lancet Gastroenterol Hepatol 2023; 8: 908–18
|
|
|
|
9 |
2 |
p. e2 |
artikel |
3 |
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
|
Danese, Silvio |
|
|
9 |
2 |
p. 133-146 |
artikel |
4 |
Endoscopic ultrasonography-guided gastroenterostomy: the end of the duodenal stent?
|
Lekkerkerker, Selma J |
|
|
9 |
2 |
p. 95-97 |
artikel |
5 |
Guselkumab in Crohn's disease: the IL-23 race continues
|
Fumery, Mathurin |
|
|
9 |
2 |
p. 97-98 |
artikel |
6 |
Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
|
Thomas, James A |
|
|
9 |
2 |
p. 159-169 |
artikel |
7 |
Inflammatory bowel disease health care for LGTBQIA+ patients
|
Dibley, Lesley |
|
|
9 |
2 |
p. 100-101 |
artikel |
8 |
Intrarectal injections of botulinum toxin versus placebo for the treatment of urge faecal incontinence in adults (FI-Toxin): a double-blind, multicentre, randomised, controlled phase 3 study
|
Leroi, Anne-Marie |
|
|
9 |
2 |
p. 147-158 |
artikel |
9 |
LGBTQIA+ affirming palliative care and communication in liver transplantation
|
Rosa, William E |
|
|
9 |
2 |
p. 106-107 |
artikel |
10 |
Management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction: the Neo-AEGIS trial
|
Weijs, Teus J |
|
|
9 |
2 |
p. 103-104 |
artikel |
11 |
Management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction: the Neo-AEGIS trial
|
Bir Yücel, Kadriye |
|
|
9 |
2 |
p. 102-103 |
artikel |
12 |
Management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction: the Neo-AEGIS trial
|
Sivarajan, Sri |
|
|
9 |
2 |
p. 102 |
artikel |
13 |
Management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction: the Neo-AEGIS trial – Authors' reply
|
Reynolds, John V |
|
|
9 |
2 |
p. 104-105 |
artikel |
14 |
Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa
|
Sonderup, Mark W |
|
|
9 |
2 |
p. 170-184 |
artikel |
15 |
Non-coeliac gluten sensitivity: from Salerno to Rome
|
Shiha, Mohamed G |
|
|
9 |
2 |
p. 94-95 |
artikel |
16 |
Parsimony prevails: Botulinum toxin and the overactive rectum
|
Knowles, Charles H |
|
|
9 |
2 |
p. 98-100 |
artikel |
17 |
Research in Brief
|
Baker, Holly |
|
|
9 |
2 |
p. 108 |
artikel |
18 |
Retracted: Endoscopic ultrasonography-guided gastroenterostomy versus uncovered duodenal metal stenting for unresectable malignant gastric outlet obstruction (DRA-GOO): a multicentre randomised controlled trial
|
Teoh, Anthony Yuen Bun |
|
|
9 |
2 |
p. 124-132 |
artikel |
19 |
The effect of expectancy versus actual gluten intake on gastrointestinal and extra-intestinal symptoms in non-coeliac gluten sensitivity: a randomised, double-blind, placebo-controlled, international, multicentre study
|
de Graaf, Marlijne C G |
|
|
9 |
2 |
p. 110-123 |
artikel |
20 |
Uncoupler therapy for NAFLD: is flushing a possible harbinger of a safety concern?
|
Taylor, Simeon I |
|
|
9 |
2 |
p. 105 |
artikel |
21 |
Uncoupler therapy for NAFLD: is flushing a possible harbinger of a safety concern? – Authors' reply
|
Noureddin, Mazen |
|
|
9 |
2 |
p. 105-106 |
artikel |
22 |
Unravelling the causes of non-coeliac gluten sensitivity
|
The Lancet Gastroenterology & Hepatology, |
|
|
9 |
2 |
p. 93 |
artikel |